Proteolytic activity profiling of Alzheimer's dementia

NIH RePORTER · NIH · F31 · $39,975 · view on reporter.nih.gov ↗

Abstract

PROJECT SUMMARY The incidence of Alzheimer’s disease (AD) and dementia continue to rise, leading to increased burden on our healthcare system. It is therefore imperative to have a comprehensive understanding of the causative mechanisms for improved treatment strategies, and potential markers for early detection and intervention for AD. One causative mechanism of neurodegenerative pathophysiology is aberrant proteolytic processing. A well- studied example of this is the proteolytic processing of amyloid precursor protein, which can lead to an increase in amyloid-β peptides, which in turn form aggregates. I aim to investigate the global role of proteolytic processing in AD by looking for differential proteolytic processing products, and by determining protease activity and specificity for a couple specific proteases implicated in disease. This will be accomplished by development and application of several different, but complementary, computational and mass spectrometry proteomics methods to investigate endogenous protease and substrate abundance profiles and cleavage motif specificity.

Key facts

NIH application ID
10066226
Project number
1F31AG069420-01
Recipient
UNIVERSITY OF WASHINGTON
Principal Investigator
Deanna Lisa Plubell
Activity code
F31
Funding institute
NIH
Fiscal year
2020
Award amount
$39,975
Award type
1
Project period
2020-08-16 → 2022-08-15